Observational Study in AS and PsA Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
Phase of Trial: Phase IV
Latest Information Update: 15 Jan 2019
Price : $35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms SPACTIVE
- Sponsors AbbVie
- 31 Aug 2018 Biomarkers information updated
- 06 Jul 2017 Status changed from active, no longer recruiting to completed.
- 25 Jan 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.